**Core Concept:**
Depot medroxyprogesterone acetate (DMPA) is a synthetic progestin, a type of hormone used in contraception. Its mode of action involves suppressing gonadotropin release, thereby preventing ovulation and menstruation. DMPA is a long-acting, injectable contraceptive used to prevent pregnancy.

**Why the Correct Answer is Right:**
The correct answer is B. DMPA causes increased risk of venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). This side effect is due to its pro-coagulant properties, as it increases blood viscosity and clotting factors, reducing the body's ability to dissolve clots and preventing clot formation.

**Why Each Wrong Option is Incorrect:**
A. This answer is incorrect as DMPA does not lead to an increased risk of breast cancer. DMPA has been shown to have a neutral effect on breast cancer risk compared to other forms of contraception.
C. This answer is incorrect as DMPA does not cause an increased risk of stroke. The risk of stroke is not significantly affected by DMPA use.
D. This answer is incorrect as DMPA does not increase the risk of liver disease. DMPA does not have a direct impact on liver function or disease risk.

**Clinical Pearl:**
Although DMPA is a highly effective contraceptive method, healthcare providers should be aware of its potential side effects such as VTE to provide informed counselling to patients considering its use. It is essential to balance the benefits of contraception against the potential risks when discussing contraceptive options with patients.